Skip to main content
LITTLE GREEN PHARMA LTD logo

LITTLE GREEN PHARMA LTD — Investor Relations & Filings

Ticker · LGP ISIN · AU0000074924 ASX Manufacturing
Open in API
Filings indexed 454 across all filing types
Latest filing 2020-10-25 Capital/Financing Update
Country AU Australia
Listing ASX LGP

About LITTLE GREEN PHARMA LTD

https://www.littlegreenpharma.com/

Little Green Pharma Ltd is a vertically integrated medicinal cannabis company focused on the cultivation, production, and distribution of pharmaceutical-grade cannabis medicines. The company operates advanced cultivation and manufacturing facilities, producing a diverse range of products including oils and dried flower. Adhering to Good Manufacturing Practice (GMP) standards, it ensures product consistency and safety across its entire supply chain, from genetics and breeding to final delivery. Little Green Pharma serves both domestic and international markets, maintaining a significant presence in Europe, including Germany and the United Kingdom. The company is committed to advancing clinical research and development to support the therapeutic use of cannabis for various medical conditions, focusing on patient-centric care and high-quality delivery systems.

Recent filings

Filing Released Lang Actions
Appendix 2A - Exercise of Options and Cleansing Notice 11 pages 416.1KB
Capital/Financing Update Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities being quoted, and the circumstances of the issue, such as options exercised or convertible securities converted. This type of document is a regulatory announcement related to capital markets and securities issuance, specifically an application for quotation of securities. It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement or certification. The document fits the category of Capital/Financing Update (CAP) because it provides updates on the issuance and quotation of new securities, which affects the company's capital structure.
2020-10-25 English
Becoming a substantial holder- Tiga Trading Pty Ltd 4 pages 176.8KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under section 671B of the Corporations Act 2001 (Cth). It details the substantial shareholding of TIGA Trading Pty Ltd in Little Green Pharma Limited, including voting power, relevant interests, acquisition dates, and associates. This type of filing is a notification of a major shareholding change, specifically the initial substantial holder notice. It is not an annual report, earnings release, or any other financial report but a regulatory disclosure about share ownership thresholds. Therefore, the correct classification is Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notice, not just an announcement or certification.
2020-10-20 English
Little Green Pharma granted GMP Licence 3 pages 661.2KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 14 October 2020 regarding Little Green Pharma being granted a Good Manufacturing Practices (GMP) licence by the Therapeutic Goods Administration (TGA). It discusses the company's regulatory achievements, manufacturing capabilities, and market positioning. The content is a corporate announcement about a licensing event and operational update rather than a financial report, earnings release, or regulatory filing. It does not contain financial statements, management discussion of financial results, or voting results. The document is approximately 6,297 characters, which is relatively short and focused on a specific operational milestone. Therefore, it fits best under the category of a general regulatory announcement or compliance update. Given the available categories, the most appropriate classification is Regulatory Filings (RNS), which serves as a fallback for miscellaneous regulatory announcements that do not fit other specific categories.
2020-10-13 English
Appendix 2A - Release from Escrow 9 pages 204.5KB
Regulatory Filings Classification · 95% confidence The document is an Appendix 2A form, which is an application for quotation of securities on the ASX (Australian Securities Exchange). It includes detailed information about the entity, the type of securities to be quoted, and compliance with ASX listing rules. This type of document is a regulatory announcement related to capital markets activity, specifically the listing or quotation of securities. It is not a financial report, earnings release, management discussion, or any other type of report. It is a formal regulatory filing announcing the application for quotation of securities, which fits best under the category of Regulatory Filings (RNS). The document is about 15,000 characters, so it is not a brief announcement of a report publication but a substantive regulatory form. Therefore, the correct classification is Regulatory Filings (RNS).
2020-10-06 English
AGM Date and Closing Date for Director Nominations 2 pages 376.4KB
AGM Information Classification · 95% confidence The document is an announcement dated 2 October 2020 regarding the scheduling of the Annual General Meeting (AGM) for Little Green Pharma Ltd, including the date, location, and closing date for director nominations. It does not contain any financial data, management discussion, or detailed report content. It is a notice about the AGM arrangements rather than the AGM materials or minutes themselves. The document length is 3562 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or about the AGM, or announcements related to the AGM. Since this is specifically about the AGM date and nomination closing date, it is best classified as AGM Information (AGM-R).
2020-10-01 English
Notice of release from escrow 2 pages 210.7KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 30 September 2020 regarding the release of securities from escrow in accordance with ASX Listing Rule 3.10A. It provides details about the number of securities being released and the release date. The content is a regulatory announcement about a capital structure event (release from escrow) but does not contain financial statements, management discussion, or detailed financial data. The document length is short (2407 characters) and it is clearly an announcement rather than a full report. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes such as escrow releases.
2020-09-29 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.